Molecular testing for BRAF mutations to inform melanoma treatment decisions: a move toward precision medicine-Reference-Cited by-同舟云学术

Molecular testing for BRAF mutations to inform melanoma treatment decisions: a move toward precision medicine

Published:2017-11-17 Issue:1 Volume:31 Page:24-38
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Mod Pathol

Author:

Cheng Liang,Lopez-Beltran Antonio,Massari Francesco,MacLennan Gregory T,Montironi Rodolfo

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine

Link

http://www.nature.com/articles/modpathol2017104.pdf

Reference113 articles.

1. American Cancer Society. Melanoma skin cancer: ACS. Available from http://www.cancer.org/acs/groups/cid/documents/webcontent/003120-pdf.pdf ; Accessed 2017.

2. Siegel RL, Miller KD, Jemal A . Cancer statistics, 2017. CA Cancer J Clin 2017;67:7–30.

3. Luke JJ, Flaherty KT, Ribas A et al. Targeted agents and immunotherapies: optimizing outcomes in melanoma. Nat Rev Clin Oncol 2017;14:463–482.

4. Atkins MB, Lotze MT, Dutcher JP et al. High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analylsis of 270 patients treated between 1985 and 1993. J Clin Oncol 1999;17:2105–2116.

5. Schiller JH, Pugh M, Kirkwood JM et al. Eastern Cooperative Group trial of interferon gamma in metastatic melanoma: an innovative study design. Clin Cancer Res 1996;2:29–36.

Cited by 313 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A lightweight deep convolutional neural network model for skin cancer image classification;Applied Soft Computing;2024-09

2. Prognostic Role of Clinicopathological Characteristics and Serum Markers in Metastatic Melanoma Patients Treated with BRAF and MEK Inhibitors;Cancers;2024-08-27

3. Innate Immune Cells in Melanoma: Implications for Immunotherapy;International Journal of Molecular Sciences;2024-08-05

4. Advancements in Melanoma Therapies: From Surgery to Immunotherapy;Current Treatment Options in Oncology;2024-07-27

5. Polyamine and EIF5A hypusination downstream of c-Myc confers targeted therapy resistance in BRAF mutant melanoma;Molecular Cancer;2024-07-04